# MESALAMINE
> **ANDA217533** · Abbreviated New Drug Application (Generic) · Sponsor: AMTA · Approved 2023-06-06
## Drug
- **FDA Application Number:** ANDA217533
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MESALAMINE
- **Generic name:** MESALAMINE
- **Active ingredients:** MESALAMINE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AMTA
- **Manufacturer:** Upsher-Smith Laboratories, LLC
- **First approval:** 2023-06-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217533)
---
*MORVS · CC0 1.0*